A California company says
its experimental blood test was able to detect many types of cancer at
an early stage and gave very few false alarms in a study that included
people with and without the disease.
Grail
Inc. gave results in a news release on Friday and will report them
Saturday at the American Society of Clinical Oncology meeting in
Chicago. They have not been published in a journal or reviewed by other
scientists.
Many
companies are trying to develop early detection “liquid biopsy” tests
that capture bits of DNA that cancer cells shed into blood.
On Thursday, Johns Hopkins University scientists launched a company
called Thrive Earlier Detection Corp. to develop its CancerSEEK test,
which yielded results similar to Grail’s more than a year ago
Entire article at
No comments:
Post a Comment